A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for
Prostate Cancer, Prostatic Neoplasms
Location: Duarte CA, Irvine CA, La Jolla CA, Atlanta GA, Grand Rapids MI,
Sponsor: Merck Sharp & Dohme LLC
Sex: Male
Age: 18+
Code: NCT06925737
Phase3, Recruiting
Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief
for
Bone Metastases, Prostate Cancer, Breast Cancer, Renal Cell Carcinoma,
Location: Hamilton
Sponsor: Hamilton Health Sciences Corporation
Sex: All
Age: 18+
Code: NCT04177056
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Birmingham AL, Gilbert AZ, Anaheim CA, La Jolla CA,
Sponsor: Celgene
Sex: Male
Age: 18+
Code: NCT06764485
Phase3, Recruiting
Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment
for
Prostate Cancer
Location: Lebanon NH
Sponsor: Ryan J. Halter
Sex: Male
Age: 18+
Code: NCT06039085
Recruiting
TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors